Context Capital Management »

Strategy shares owned by Context Capital Management

Quarter-by-quarter ownership of Strategy shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Strategy

Tip: Access up to 7 years of quarterly data

All positions including Strategy held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Strategy by Context Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $188M 228M 0.82

More positions owned by Context Capital Management

Strategy Note 12/0 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Peloton Interactive Note 5.500%12/0 (Principal)
Mara Holdings Note 6/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Fluence Energy Note 2.250% 6/1 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Tandem Diabetes Care Note 1.500% 3/1 (Principal)
Travere Therapeutics Note 2.250% 3/0 (Principal)
Cleanspark Note 6/1 (Principal)
Enovis Corporation Note 3.875%10/1 (Principal)
Pennymac Corp Note 8.500% 6/0 (Principal)
Century Alum Note 2.750% 5/0 (Principal)

View all positions for Context Capital Management

Top funds holding Strategy

Ing Investment Management
Aristeia Capital
Context Capital Management
Calamos Advisors
Verition Fund Management
LMR Partners
Whitebox Advisors
Marshall Wace
State Street Corporation
Point72 Asset Management
Wolverine Asset Management
Capital World Investors
Lazard Asset Management
Shenkman Capital Management
Bnp Paribas Arbitrage, Snc

View all funds holding Strategy